Which Cannabis Compounds Have Been Tested for Gut Problems, and What the Trials Found About Symptoms Versus Inflammation
Comments Off on Which Cannabis Compounds Have Been Tested for Gut Problems, and What the Trials Found About Symptoms Versus Inflammation
September 4, 2026
Cannabis for gastrointestinal symptoms has been tested more carefully than most cannabis indications, and four randomized trials in Crohn's disease and ulcerative colitis produced the same uncomfortable result: symptom scores and quality of life improved…
GLP-1 Receptor Agonists and Colorectal Cancer Risk
Comments Off on GLP-1 Receptor Agonists and Colorectal Cancer Risk
April 23, 2026
GLP-1 receptor agonists colorectal cancer risk reduction is an emerging benefit supported by observational evidence. These agents may reduce colorectal cancer risk through improved insulin sensitivity and reduced inflammation. This adds to their known…
Some Common IBS Treatments Linked to Higher Mortality Risk, Study Shows
Comments Off on Some Common IBS Treatments Linked to Higher Mortality Risk, Study Shows
April 8, 2026
New research highlights IBS treatment safety concerns linked to increased mortality risk. Cannabis-based therapies may offer safer alternatives for IBS symptom management. Understanding these risks is crucial for patients and clinicians.
